| Serial Number | 90311854 |
| Word Mark | RAKUTEN MEDICAL |
| Filing Date | Wednesday, November 11, 2020 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Monday, September 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 15, 2021 |
| Goods and Services | Educational services, providing training in the field of medicines, medical devices, pharmaceuticals, clinical trials and health care; Teaching and training services, namely, courses, classes, lessons and seminars in the field of medicines, pharmaceuticals and health care; Arranging, conducting and organization of congresses, conferences, conventions and symposiums in the field of medicines, pharmaceuticals and health care; Educational services, namely, providing classes, seminars, and lectures, all in the field of the diagnosis and treatment of cancer; education in the nature of classes, seminars, and training in the oncology field |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Cancer treatment agent in the nature of pharmaceutical preparations; Pharmaceutical drugs for cancer treatment; Diagnostic agent used for cancer; Pharmaceutical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral disorders and diseases; Medical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral disorders and diseases; Diagnostic preparations for medical purposes |
| Goods and Services | Compilation of statistical data relating to medical research for business purposes |
| Goods and Services | Medical services; Medical information; Providing medical information from a web site; Medical testing for diagnostic or treatment purposes; Medical treatment services; Medical care services; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical services in the field of oncology; Medical consultation; Medical advisory services; Compilation of medical reports, namely, medical reporting services; Issuing of medical reports, namely, medical reporting services; Medical and healthcare clinics; Medical assistance; Healthcare services; Rental of medical machines and apparatus; Consultancy and information services relating to the diagnostic, prophylactic, and therapeutic properties of medical products; Providing information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; Counselling services, namely, medical counselling for patients diagnosed with cancer; Information services in the field of diagnosing and treating cancer; Providing online information services, namely, prescription drug information regarding diagnostic, prophylactic, and therapeutic properties; Providing information in the field of medicine; Providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via a website; Providing information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via an online searchable database; Medical diagnostic testing and reporting services; Genetic testing for diagnostic and treatment purposes; Providing healthcare information regarding cancer drugs and cancer treatment; Maintaining personal medical history records and files |
| NOT AVAILABLE | "MEDICAL" |
| Goods and Services | Medical devices, apparatus and instruments for detecting and treating cancer, namely, lasers for medical use, lasers for medical purposes, lasers for medical use; Dental devices, apparatus and instruments for detecting and treating cancer namely, lasers for dental use, lasers for dental purposes, lasers for dental use |
| Goods and Services | Testing and research on medical treatment methods and techniques; Provision of medical and scientific research information on clinical trials; Research and development in the field of immunology; Testing and research on pharmaceuticals; Medical and pharmacological research services and clinical trials for others; Research, development, and consultation related thereto in the field of medicine; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical drug development services; Medical laboratories; Design and development of medical technology; Scientific, biological and medical research; Conducting clinical trials for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, April 26, 2024 |
| First Use In Commerce Date | Friday, April 26, 2024 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | Tuesday, January 31, 2023 |
| First Use In Commerce Date | Tuesday, January 31, 2023 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, January 10, 2023 |
| First Use In Commerce Date | Tuesday, January 10, 2023 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 041 |
| First Use Anywhere Date | Tuesday, January 10, 2023 |
| First Use In Commerce Date | Tuesday, January 10, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, March 1, 2019 |
| First Use In Commerce Date | Friday, March 1, 2019 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 11, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, March 1, 2019 |
| First Use In Commerce Date | Friday, March 1, 2019 |
| Party Name | RAKUTEN GROUP, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SETAGAYA-KU, TOKYO 158-0094 JP |
| Party Name | RAKUTEN GROUP, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SETAGAYA-KU, TOKYO 158-0094 JP |
| Party Name | Rakuten, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Setagaya-ku, Tokyo 158-0094 JP |
| Event Date | Event Description |
| Saturday, November 14, 2020 | NEW APPLICATION ENTERED |
| Monday, January 11, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 14, 2021 | ASSIGNED TO EXAMINER |
| Friday, April 23, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 23, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, April 23, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 23, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 23, 2021 | SUSPENSION LETTER WRITTEN |
| Friday, April 23, 2021 | LETTER OF SUSPENSION E-MAILED |
| Friday, April 23, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 5, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, May 10, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 15, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 15, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 24, 2021 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Monday, July 19, 2021 | ASSIGNED TO PETITION STAFF |
| Tuesday, July 20, 2021 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Tuesday, August 10, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 20, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 20, 2022 | SOU EXTENSION 1 FILED |
| Thursday, January 20, 2022 | SOU EXTENSION 1 GRANTED |
| Saturday, January 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 5, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 5, 2022 | SOU EXTENSION 2 FILED |
| Friday, August 5, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, August 9, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 23, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 23, 2023 | SOU EXTENSION 3 FILED |
| Monday, January 23, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, January 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 8, 2023 | SOU EXTENSION 4 FILED |
| Tuesday, August 8, 2023 | SOU EXTENSION 4 GRANTED |
| Thursday, August 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 26, 2023 | ASSIGNED TO EXAMINER |
| Monday, February 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 5, 2024 | SOU EXTENSION 5 FILED |
| Wednesday, February 21, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 21, 2024 | SOU EXTENSION 5 GRANTED |
| Thursday, February 22, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 5, 2024 | USE AMENDMENT FILED |
| Monday, August 5, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, August 7, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, September 9, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | SU - NON-FINAL ACTION - WRITTEN |